829TiPMulticenter randomized phase II trial of...

Annals of Oncology 2019 / 10 Vol. 30; Iss. Supplement

829TiPMulticenter randomized phase II trial of 5-fluorouracil/leucovorin (5-FU/LV) with or without liposomal irinotecan (nal-IRI) in metastatic biliary tract cancer (BTC) as second-line therapy after progression on gemcitabine plus cisplatin (GemCis): NIFTY trial

Yoo, C, Jeong, J H, Kim, K-P, Cheon, J, Kim, I, Kang, M, Ryu, H, Kang, B W, Ryoo, B-Y
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
30
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdz247.155
Date:
October, 2019
File:
PDF, 77 KB
2019
Conversion to is in progress
Conversion to is failed